za regulacj pigmentacji skry poprzez pobudzanie melanocytw do produkcji melaniny
Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice
Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects
After the Civil War, traction for the movement increased, fueled largely by the Womens Christian Temperance Union
Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I (2016) Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation
WARNING: Do not take this product if you are pregnant or nursing